Clinical Trials Directory

Trials / Unknown

UnknownNCT02612870

Sienna+® Injection Time Study 4 Arms

Sienna+® Injection Time Study: A Prospective Multicentre, Controlled Clinical Trial to Evaluate the Performance of Superparamagnetic Iron Oxide vs. Standard Technique as Tracer in Sentinel Node Biopsy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Kantonsspital Baden · Academic / Other
Sex
Female
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Patients with breast cancer normally undergo a labelling with radioactive tracer typically 1 day before surgery, which enables the surgeon to localize the sentinel lymph node during surgery. This pilot study uses the magnetic Sentimag technique to mark the lymph nodes either 1 or 4-6 days before surgery to investigate the concordance with the standard technique.

Detailed description

Sienna+® is injected either 1 day or 4-6 days before surgery, either retro-mamillary or peri-tumorally: * Sienna+® retro-mamillary 1 day before surgery: 10 patients * Sienna+® peri-tumorally 1 day before surgery: 10 patients * Sienna+® retro-mamillary 4-6 days before surgery: 10 patients * Sienna+® peri-tumorally 4-6 days before surgery: 10 patients In each case, Technetium as standard technique is employed according to the gold standard protocol one day before surgery. The Sentimag device is used during surgery to detect the lymph nodes in parallel to the standard technique.

Conditions

Interventions

TypeNameDescription
DEVICESienna+ retroSentinel node marking with Sienna+ retro-mamillary 1 day before surgery
DEVICESienna+ periSentinel node marking with Sienna+ peri-tumorally 1 day before surgery
DEVICESienna+ retro 4-6Sentinel node marking with Sienna+ retro-mamillary 4-6 days before surgery
DEVICESienna+ peri 4-6Sentinel node marking with Sienna+ peri-tumorally 4-6 days before surgery
DEVICETechnetium 1Sentinel node marking with Technetium 1 day before surgery

Timeline

Start date
2016-02-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-11-24
Last updated
2015-11-24

Locations

2 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02612870. Inclusion in this directory is not an endorsement.